recombinant classical swine fever virus, live classical swine fever vaccine, methods to protect an animal against classical swine fever, to differentiate animals infected with classical swine fever virus from uninfected animals or animals vaccinated with swine fever vaccine and to isolate an infectious recombinant classical swine fever virus, cdna molecule, use of the infectious recombinant classical swine fever virus, and, peptide-based elisa

摘要

The invention relates to a recombinant classical swine fever virus (CSFV). A preferred recombinant CSFV comprises a deletion of at least one amino acid in a "TAVSPTTLR" domain of the E2 protein. The invention further relates to a vaccine comprising the recombinant CSFV, a method for generating a recombinant CSFV, and use of a recombinant CSFV.